The more Americans who take Ozempic, the faster the US economy could grow, Goldman Sachs says
businessinsider.com/us-economy-faster-growth-ozempic-glp-1-weight-loss-drugs-2024-2
Ozempic.
Getty Images
The US economy could see a surge in growth as more people start to take GLP-1 weight-loss drugs.
Goldman Sachs predicted that US GDP could jump by 1% if 60 million Americans took a GLP-1 drug.
Goldman Sachs also said that "poor health imposes significant economic costs."
The more people who take GLP-1 weight-loss drugs, the faster the US economy could…
This story appeared on businessinsider.com, .